HDAC9 and glioblastoma: Recent findings from our lab have highlighted that in GBM model systems HDAC inhibitors block glycolysis and in turn activate oxidative phosphorylation fueled by fatty acid oxidation to counteract cell death and inhibition of proliferation [13].